Successful Shortening of Tuberculosis Treatment Using Adjuvant Host-Directed Therapy with FDA-Approved Phosphodiesterase Inhibitors in the Mouse Model

Global control of tuberculosis (TB), an infectious disease that claims nearly 2 million lives annually, is hindered by the long duration of chemotherapy required for curative treatment. Lack of adherence to this intense treatment regimen leads to poor patient outcomes, development of new or addition...

Descripción completa

Detalles Bibliográficos
Autores principales: Maiga, Mamoudou, Agarwal, Nisheeth, Ammerman, Nicole C., Gupta, Radhika, Guo, Haidan, Maiga, Marama C., Lun, Shichun, Bishai, William R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272040/
https://www.ncbi.nlm.nih.gov/pubmed/22319585
http://dx.doi.org/10.1371/journal.pone.0030749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272040/
https://www.ncbi.nlm.nih.gov/pubmed/22319585
http://dx.doi.org/10.1371/journal.pone.0030749

Ejemplares similares